These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25951751)

  • 1. Hypofibrinogenemia induced by tigecycline: a potentially life-threatening coagulation disorder.
    Sabanis N; Paschou E; Gavriilaki E; Kalaitzoglou A; Vasileiou S
    Infect Dis (Lond); 2015; 47(10):743-6. PubMed ID: 25951751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case report of patient with severe acute cholangitis with tigecycline treatment causing coagulopathy and hypofibrinogenemia.
    Wu X; Zhao P; Dong L; Zhang X
    Medicine (Baltimore); 2017 Dec; 96(49):e9124. PubMed ID: 29245350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects.
    Candel FJ; Calvo N; Head J; Sánchez A; Matesanz M; Culebras E; Barrientos A; Picazo J
    Rev Esp Quimioter; 2010 Jun; 23(2):103-8. PubMed ID: 20559610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
    Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
    J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii.
    Mutlu Yilmaz E; Sunbul M; Aksoy A; Yilmaz H; Guney AK; Guvenc T
    Int J Antimicrob Agents; 2012 Oct; 40(4):332-6. PubMed ID: 22831842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety profile comparison of colistin and tigecycline on the extensively drug resistant Acinetobacter baumannii.
    Kwon SH; Ahn HL; Han OY; La HO
    Biol Pharm Bull; 2014; 37(3):340-6. PubMed ID: 24583855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections.
    Ku K; Pogue JM; Moshos J; Bheemreddy S; Wang Y; Bhargava A; Campbell M; Khandker N; Lephart PR; Chopra T; Hayakawa K; Martin ET; Abreu-Lanfranco O; Dhar S; Kaye KS; Marchaim D
    Am J Infect Control; 2012 Dec; 40(10):983-7. PubMed ID: 22440526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-resistant Acinetobacter baumannii mediastinitis treated successfully with tigecycline: a case report.
    Tekçe AY; Erbay A; Çabadak H; Yağcı S; Karabiber N; Şen S
    Surg Infect (Larchmt); 2011 Apr; 12(2):141-3. PubMed ID: 21348768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii.
    Ozbek B; Sentürk A
    Chemotherapy; 2010; 56(6):466-71. PubMed ID: 21088399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged and high dosage of tigecycline - successful treatment of spondylodiscitis caused by multidrug-resistant Acinetobacter baumannii: a case report.
    Tsachouridou O; Georgiou A; Nanoudis S; Chrysanthidis T; Loli G; Morfesis P; Zebekakis P; Metallidis S
    J Med Case Rep; 2017 Jul; 11(1):186. PubMed ID: 28687078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.
    Schafer JJ; Goff DA; Stevenson KB; Mangino JE
    Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-resistant Acinetobacter baumannii infection in children.
    De Luca M; Angelino G; Calò Carducci FI; Martino A; Bernardi S; Bernaschi P; Carletti M; D'Argenio P; Palma P
    BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22688471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is tigecyclin a good choice in the treatment of multidrug-resistant Acinetobacter baumannii pneumonia?
    Tasbakan MS; Pullukcu H; Sipahi OR; Tasbakan MI; Aydemir S; Bacakoglu F
    J Chemother; 2011 Dec; 23(6):345-9. PubMed ID: 22233818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis.
    Tutuncu EE; Kuscu F; Gurbuz Y; Ozturk B; Haykir A; Sencan I
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e224-6. PubMed ID: 19962335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of tigecycline for secondary Acinetobacter bacteremia and factors associated with treatment failure.
    Liou BH; Lee YT; Kuo SC; Liu PY; Fung CP
    Antimicrob Agents Chemother; 2015; 59(6):3637-40. PubMed ID: 25824230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose tigecycline-associated alterations in coagulation parameters in critically ill patients with severe infections.
    Routsi C; Kokkoris S; Douka E; Ekonomidou F; Karaiskos I; Giamarellou H
    Int J Antimicrob Agents; 2015 Jan; 45(1):90-3. PubMed ID: 25241261
    [No Abstract]   [Full Text] [Related]  

  • 18. Multidrug-resistant Acinetobacter baumannii bacteremia treated with tigecycline in two pediatric burn patients.
    Kanık-Yüksek S; Tezer H; Ozkaya-Parlakay A; Gulhan B; Sayed-Oskovi H; Kara A; Şenel E
    Pediatr Infect Dis J; 2015 Jun; 34(6):677. PubMed ID: 25970113
    [No Abstract]   [Full Text] [Related]  

  • 19. Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals.
    Al-Sweih NA; Al-Hubail MA; Rotimi VO
    J Chemother; 2011 Feb; 23(1):13-6. PubMed ID: 21482488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral spinal fluid penetration of tigecycline in a patient with Acinetobacter baumannii cerebritis.
    Ray L; Levasseur K; Nicolau DP; Scheetz MH
    Ann Pharmacother; 2010 Mar; 44(3):582-6. PubMed ID: 20179255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.